# 68Ga-NY104 PET/CT in Von Hippel-Lindau Disease

> **NCT05810246** · PHASE2 · UNKNOWN · sponsor: **Peking Union Medical College Hospital** · enrollment: 19 (estimated)

## Conditions studied

- Von Hippel-Lindau Disease

## Interventions

- **DIAGNOSTIC_TEST:** 68Ga-NY104 PET/CT Contrast-enhanced MRI of the brain and contrast-enhanced CT of abdomen and pelvis) 68Ga-NODAGA-LM3 PET/CT (exploratory)

## Key facts

- **NCT ID:** NCT05810246
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-05-01
- **Primary completion:** 2025-05-01
- **Final completion:** 2025-12-31
- **Target enrollment:** 19 (ESTIMATED)
- **Last updated:** 2023-05-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05810246

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05810246, "68Ga-NY104 PET/CT in Von Hippel-Lindau Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05810246. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*